These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37612265)

  • 21. LncRNA LINC00511 promotes COL1A1-mediated proliferation and metastasis by sponging miR-126-5p/miR-218-5p in lung adenocarcinoma.
    Wang Y; Mei X; Song W; Wang C; Qiu X
    BMC Pulm Med; 2022 Jul; 22(1):272. PubMed ID: 35842617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. APE1 stimulates EGFR-TKI resistance by activating Akt signaling through a redox-dependent mechanism in lung adenocarcinoma.
    Lu GS; Li M; Xu CX; Wang D
    Cell Death Dis; 2018 Oct; 9(11):1111. PubMed ID: 30382076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downregulation of Linc00173 increases BCL2 mRNA stability via the miR-1275/PROCA1/ZFP36L2 axis and induces acquired cisplatin resistance of lung adenocarcinoma.
    Tao X; Li Y; Fan S; Wu L; Xin J; Su Y; Xian X; Huang Y; Huang R; Fang W; Liu Z
    J Exp Clin Cancer Res; 2023 Jan; 42(1):12. PubMed ID: 36627670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Agmatinase promotes the lung adenocarcinoma tumorigenesis by activating the NO-MAPKs-PI3K/Akt pathway.
    Zhu HE; Yin JY; Chen DX; He S; Chen H
    Cell Death Dis; 2019 Nov; 10(11):854. PubMed ID: 31699997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Desmoglein-2 modulates tumor progression and osimertinib drug resistance through the EGFR/Src/PAK1 pathway in lung adenocarcinoma.
    Jin R; Wang X; Zang R; Liu C; Zheng S; Li H; Sun N; He J
    Cancer Lett; 2020 Jul; 483():46-58. PubMed ID: 32272148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [S100A10 promotes proliferation and invasion of lung adenocarcinoma cells by activating the Akt-mTOR signaling pathway].
    Wang H; Sun Z; Zhao W; Geng B
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 May; 43(5):733-740. PubMed ID: 37313814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The long noncoding RNA LINC00483 promotes lung adenocarcinoma progression by sponging miR-204-3p.
    Yang S; Liu T; Sun Y; Liang X
    Cell Mol Biol Lett; 2019; 24():70. PubMed ID: 31889958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CLDN18.1 attenuates malignancy and related signaling pathways of lung adenocarcinoma in vivo and in vitro.
    Luo J; Chimge NO; Zhou B; Flodby P; Castaldi A; Firth AL; Liu Y; Wang H; Yang C; Marconett CN; Crandall ED; Offringa IA; Frenkel B; Borok Z
    Int J Cancer; 2018 Dec; 143(12):3169-3180. PubMed ID: 30325015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The miR-4732-5p/XPR1 axis suppresses the invasion, metastasis, and epithelial-mesenchymal transition of lung adenocarcinoma
    Hu Y; Bai J; Zhou D; Zhang L; Chen X; Chen L; Liu Y; Zhang B; Li H; Yin C
    Mol Omics; 2022 Jun; 18(5):417-429. PubMed ID: 35388387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Signal peptidase 21 suppresses cell proliferation, migration, and invasion via the PTEN-PI3K/Akt signaling pathway in lung adenocarcinoma.
    Zhang N; Cao S; Sun R; Wang Y; Liu L; Wang W; Meng X
    PeerJ; 2022; 10():e14206. PubMed ID: 36275477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SAM68 promotes tumorigenesis in lung adenocarcinoma by regulating metabolic conversion via PKM alternative splicing.
    Zhu S; Chen W; Wang J; Qi L; Pan H; Feng Z; Tian D
    Theranostics; 2021; 11(7):3359-3375. PubMed ID: 33537092
    [No Abstract]   [Full Text] [Related]  

  • 32. CCNE1 Promotes Progression and is Associated with Poor Prognosis in Lung Adenocarcinoma.
    Ma G; Yang L; Dong J; Zhang L
    Curr Pharm Biotechnol; 2022; 23(9):1168-1178. PubMed ID: 34792009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Knockdown of replication protein A 3 induces protective autophagy and enhances cisplatin sensitivity in lung adenocarcinoma by inhibiting AKT/mTOR signaling via binding to cyclin-dependent kinases regulatory subunit 2.
    Chen L; Hu K; Liu Y; Liu L; Tang J; Qin X
    Drug Dev Res; 2022 Nov; 83(7):1589-1599. PubMed ID: 35903032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FLOT1 promotes tumor development, induces epithelial-mesenchymal transition, and modulates the cell cycle by regulating the Erk/Akt signaling pathway in lung adenocarcinoma.
    Zhang L; Mao Y; Mao Q; Fan W; Xu L; Chen Y; Xu L; Wang J
    Thorac Cancer; 2019 Apr; 10(4):909-917. PubMed ID: 30838797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Junctional adhesion molecule-like protein as a novel target for kaempferol to ameliorate lung adenocarcinoma.
    Wu Q; Wang YB; Che XW; Wang H; Wang W
    J Integr Med; 2023 May; 21(3):268-276. PubMed ID: 37069006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipid oversupply induces CD36 sarcolemmal translocation via dual modulation of PKCζ and TBC1D1: an early event prior to insulin resistance.
    Zhu B; Li MY; Lin Q; Liang Z; Xin Q; Wang M; He Z; Wang X; Wu X; Chen GG; Tong PC; Zhang W; Liu LZ
    Theranostics; 2020; 10(3):1332-1354. PubMed ID: 31938068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Silencing LINC01116 suppresses the development of lung adenocarcinoma via the AKT signaling pathway.
    Shang B; Li Z; Li M; Jiang S; Feng Z; Cao Z; Wang H
    Thorac Cancer; 2021 Jul; 12(14):2093-2103. PubMed ID: 34061456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. STAMBP promotes lung adenocarcinoma metastasis by regulating the EGFR/MAPK signaling pathway.
    Xu H; Yang X; Xuan X; Wu D; Zhang J; Xu X; Zhao Y; Ma C; Li D
    Neoplasia; 2021 Jun; 23(6):607-623. PubMed ID: 34102455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new leptin-mediated mechanism for stimulating fatty acid oxidation: a pivotal role for sarcolemmal FAT/CD36.
    Momken I; Chabowski A; Dirkx E; Nabben M; Jain SS; McFarlan JT; Glatz JF; Luiken JJ; Bonen A
    Biochem J; 2017 Jan; 474(1):149-162. PubMed ID: 27827305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The fatty acid receptor CD36 promotes HCC progression through activating Src/PI3K/AKT axis-dependent aerobic glycolysis.
    Luo X; Zheng E; Wei L; Zeng H; Qin H; Zhang X; Liao M; Chen L; Zhao L; Ruan XZ; Yang P; Chen Y
    Cell Death Dis; 2021 Mar; 12(4):328. PubMed ID: 33771982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.